of their coronavirus vaccine. They hope to have the first results of the trial by December and if it is successful they will move on to further trials by the end of the year. Key facts & figures in 2012 Sanofi Pasteur 2012 net sales: €3,897 million (+5.7% over 2011) Staff: nearly 13,000 employees worldwide More than 1 billion doses of vaccines produced yearly to immunize more than 500 million people in the world Largest product range available, against 20 infectious diseases More than €1 million invested every day in R&D Nearly €2 billion invested in the last 5 years in production infrastructures. Headquarters: Lyon, France 14 production and/or R&D sites located in: Marcy-l'Étoile and Val-de-Reuil, France Swiftwater, Pennsylvania (Sanofi Pasteur's United States headquarters), Cambridge, Massachusetts and Canton, Massachusetts, Orlando, Florida and Rockville, Maryland, United States Toronto, Ontario, Canada Pilar, Buenos Aires Province, Argentina Shenzhen, China Hyderabad, India Ocoyoacac, Mexico Chachoengsao, Thailand Neuville-sur-Saône, France Vaccines This list is for vaccines with trade names; Sanofi Pasteur also produces many generic vaccines which do not have trade names Cancer vaccines bladder cancer: TheraCys Coronavirus vaccines A COVID-19 vaccine is under development by the French pharmaceutical and the British pharmaceutical company GlaxoSmithKline. Advanced clinical trials of the vaccine were delayed in December 2020 after it failed to produce a strong immune response in people over the age of 50, most likely due to an insufficient antigen concentration in the vaccine, delaying the launch of the vaccine to late 2021. Dengue vaccines Dengvaxia, approved in 18 countries DPT vaccines Adacel Daptacel Tripedia (Trepedia), discontinued, last shipped in 2012 Haemophilus influenzae type b vaccines ActHIB Hepatitis A vaccines Avaxim 160 U (or just Avaxim) Hepatitis B vaccines Genhevac B Pasteur Hbvaxpro (5, 10 and 40 μg) Influenza vaccines Addigrip Flublok Quadrivalent Fluzone High-Dose Fluzone (standard-dose; without preservatives; pediatric dose without preservatives) Sandovac Vaxigrip Japanese encephalitis virus vaccines JE-VAX Measles vaccines Rouvax Meningococcal vaccines Menactra, the first meningococcal vaccine approved for use in infants Menomune-A/C/Y/W-135 Vaccin Meningococcique A+C MMR vaccines M-M-RVaxPro Pneumonia vaccines Pneumo 23 Polio vaccines Imovax Polio Ipol Polio Salk Rabies vaccines IMOVAX RABIES (Imovax) Imogam Rabies-HT, rabies immune globulin Vaccin Rabique Pasteur Rubella vaccines Rudivax Smallpox vaccines ACAM 2000 Tetanus vaccines Vaccin Tetanique Pasteur Tuberculosis vaccines Mycobax Tubersol Vaccin Bcg Ssi Typhoid fever vaccines Typhim Vi Yellow fever vaccines Stamaril YF-VAX Diphtheria and tetanus combined vaccines DECAVAC dT reduct D. T. Vax Diphtheria,